Heme oxygenase-1 (HO-1) dysregulation marks a persistent oxidative microenvironment in brain microglia in adult rats following perinatal chorioamnionitis

The brain is not a static organ; it is a living landscape that must constantly repair itself, especially when injured. One of the most critical workers in this landscape is the microglia, a type of immune cell that lives exclusively within the brain. Think of these cells as the brain's dedicated maintenance crew: they patrol the neural environment, cleaning up debris, pruning unnecessary connections, and responding to threats. Under normal conditions, they are calm and efficient. However, when the brain faces severe stress or injury, these cells can become overactive, shifting from helpful caretakers into sources of chronic inflammation that can damage the very tissue they are meant to protect.

A key factor in how these cells respond to stress is an enzyme called heme oxygenase-1. This protein acts as a stress regulator, helping cells manage oxidative damage—a form of cellular wear and tear caused by harmful chemical reactions. In a healthy brain, this enzyme is carefully controlled, rising just enough to protect cells and then returning to baseline. But when this regulation breaks down and the enzyme stays elevated for too long, it can create a toxic environment that fuels persistent inflammation rather than healing it. This imbalance is particularly concerning when it happens early in life, such as during a pregnancy complicated by chorioamnionitis, a severe infection of the placenta that can trigger a fetal inflammatory response. While doctors know this condition increases the risk of brain injury in newborns, it has remained unclear whether the cellular damage caused by this early inflammation fades away as the child grows, or if it leaves a permanent mark on the brain's immune system that lasts into adulthood.

A team of researchers at Johns Hopkins University set out to answer this question by looking directly at the microglia in the brains of rats that had experienced this type of early-life infection. They wanted to see if the brain's immune cells had returned to a normal state once the animals reached adulthood, or if they were still stuck in a state of distress. To do this, they used a highly sensitive technique called flow cytometry, which allows scientists to sort and analyze individual cells from a tissue sample. They examined the brains of rats at two specific stages: when they were young adults, roughly equivalent to a human teenager, and again when they were fully mature adults. By comparing these rats to a control group that did not experience the infection, the researchers could track exactly how the infection changed the behavior and chemistry of the brain's immune cells over time.

The study focused on three distinct groups of microglia, identified by specific markers on their surfaces that act like name tags. These markers tell researchers whether a cell is in a resting state, an inflammatory state, or a transitional state where it is shifting between the two. The researchers also measured the levels of heme oxygenase-1 inside each of these cells to see if the stress response was still active. They found that while the overall number of immune cells in the brain did not change significantly between the infected and uninfected groups, the internal state of the cells had been permanently altered. In the rats that had suffered the early infection, the brain's immune cells were not behaving like a healthy, mature adult population. Instead, they were stuck in a pattern that suggested the brain was still fighting a battle it had started years earlier.

Specifically, the researchers observed that the infection changed the balance of these microglia subtypes as the rats aged. In a healthy brain, the population of cells with an inflammatory signature naturally decreases as the animal matures. However, in the rats with a history of infection, this decline did not happen. Instead, the population of inflammatory cells actually increased significantly by the time the animals reached adulthood. Furthermore, these cells showed a distinct chemical signature of oxidative stress. The levels of heme oxygenase-1 inside the microglia of the infected rats were much higher than in the healthy rats, indicating that the cells were still under severe chemical stress. This elevation was not limited to just one type of cell; it was found across the different microglia subtypes, suggesting a widespread disruption in the brain's ability to calm down after the initial injury.

The researchers also looked at a marker called CD163, which is often associated with the cleanup phase of inflammation. In the infected rats, the expression of this marker was altered in a way that suggested the inflammation was not resolving properly. Instead of moving through the stages of injury and repair, the cells seemed to be lingering in a state of chronic activation. The combination of high levels of the stress enzyme and the altered CD163 patterns pointed to a specific problem: the brain's immune system had failed to reset itself. The cells were not just reacting to a new threat; they were carrying the scars of the early infection, maintaining a toxic, oxidative environment that could potentially harm the brain's long-term health.

This study provides the first clear evidence that the effects of perinatal chorioamnionitis extend far beyond the immediate newborn period. The findings suggest that the brain's immune system can be "programmed" by early-life inflammation in a way that persists into adulthood, creating a hidden, ongoing burden of neuroinflammation. The researchers did not find that the total number of immune cells increased, which rules out the idea that the brain is simply flooded with new invaders. Instead, the problem lies in the behavior and chemistry of the existing cells, which have been pushed into a dysfunctional state. The study indicates that the brain's attempt to heal from early infection may have gone wrong, leaving the immune cells in a state of perpetual, low-level distress that could contribute to long-term neurological issues.

The work highlights a critical gap in our understanding of how early-life infections affect the developing brain. It suggests that the damage is not always visible as a loss of tissue or a sudden event, but rather as a subtle, persistent change in the cellular environment. The researchers noted that their study had limitations, such as not being able to map exactly where these changes occurred in different parts of the brain or determining the specific functional consequences of these altered cells. They also did not have enough data to determine if these effects differed between male and female rats. However, the core finding remains robust: the brain's immune cells in adult rats that experienced perinatal infection were fundamentally different from those in healthy rats, characterized by a failure to resolve inflammation and a continued state of oxidative stress.

Ultimately, this research paints a picture of a brain that never fully recovers from an early assault. The microglia, which should be the guardians of neural health, become the carriers of a chronic, unresolved problem. The elevated levels of heme oxygenase-1 serve as a molecular fingerprint of this ongoing struggle, a sign that the cells are still trying to manage a threat that is no longer present. By identifying these specific cellular changes, the study opens the door to understanding how early-life events can shape brain health decades later, offering a potential target for future therapies aimed at helping the brain reset its immune system and break the cycle of chronic inflammation.